<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tII-ijmm-46-02-0489" orientation="portrait" position="float">
 <label>Table II</label>
 <caption>
  <p>FDA-approved drugs with SARS-CoV2 antiviral actions.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top" align="left" rowspan="1" colspan="1">Substance analyzed (Ref.)</th>
    <th valign="top" align="left" rowspan="1" colspan="1">Viral molecule inhibited; mechanism</th>
    <th valign="top" align="left" rowspan="1" colspan="1">Method and/or software used for testing FDA approved drugs</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Hydroxychloroquine and azithromycin (
     <xref rid="b59-ijmm-46-02-0489" ref-type="bibr">59</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Spike 
     <bold>(</bold>S) Protein - binding motifs of ACE2 receptor;
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Virtualized quantum mechanical modeling</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Eptifibatide acetate, TNP, GNF5, GR 127935, RS504393 (
     <xref rid="b62-ijmm-46-02-0489" ref-type="bibr">62</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">ACE2 receptor protein of host cells binding site</td>
    <td valign="top" align="left" rowspan="1" colspan="1">High-throughput virtual screening used to investigate LOPAC library drugs</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">KT185, KT203 GSK1838705A, BMS195614, RS504393 (
     <xref rid="b62-ijmm-46-02-0489" ref-type="bibr">62</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">S-protein (RBD of spike protein) binding site anti-inflammatory</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Software: PyRx, Open Babel, AutoDock Vina, PyMol, GROMACS; online resources SWISS MODEL, HADDOCK, RCSB PDB, NCBI, ProCheck at RCSB validation server, ProSA-web, SAVES-Verify3D server</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Darunavir, Nelfinavir,</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Protease:</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Structure-based drug repositioning</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Saquinavir, Rosuvastatin (
     <xref rid="b63-ijmm-46-02-0489" ref-type="bibr">63</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Mpro, central site</td>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Montelukast, Fexofenadine (
     <xref rid="b63-ijmm-46-02-0489" ref-type="bibr">63</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Protease:</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Structure-based drug repositioning</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1">Mpro, terminal site</td>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Chloroquine,</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Protease:</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Homology model of the protease based on</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">formoterol, 16 other FDA-</td>
    <td valign="top" align="left" rowspan="1" colspan="1">papain-like protease</td>
    <td valign="top" align="left" rowspan="1" colspan="1">SARS-coronavirus PLpro structure; drugs</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">approved drugs (
     <xref rid="b60-ijmm-46-02-0489" ref-type="bibr">60</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">(PLpro)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">docked in S3/S4 pockets of active site</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Remdesivir (-13.1 KJ/mol)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Protease</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Connectivity map and the docking configurations used to simulate the docking bonding energy between antiviral and the respective protease in KJ/mol</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>cloperastine</italic> (-10.4)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">3CLpro (PDB ID 6LU7)</td>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>vigabatrin</italic> (-10.2)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">methotrexate (-6.9)</td>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Remdesivir (-18.6 KJ/mol)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Protease</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Used PyRx for loading and visualising the SDF files for</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>vigabatrin</italic> (-12.1)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">6Y84 - main protease with</td>
    <td valign="top" align="left" rowspan="1" colspan="1">the ligands and the AutoDock Vina tool for testing the</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>cloperastine</italic> (-10.1) nicer-
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">unliganded active site</td>
    <td valign="top" align="left" rowspan="1" colspan="1">docking on two target proteins 6LU7 and 6Y84 from PDB</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">goline (-9.0) phenazo-</td>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">pyridine (-8.4) (
     <xref rid="b64-ijmm-46-02-0489" ref-type="bibr">64</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Pemirolast (
     <xref rid="b65-ijmm-46-02-0489" ref-type="bibr">65</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Protease; RNA Replicase inhibitor</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Using COVID-19 Docking Server</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Chloroquine (
     <xref rid="b37-ijmm-46-02-0489" ref-type="bibr">37</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Accessory proteins prevents binding of orf1ab, ORF3a, ORF10 to heme, ORF8, surface glycoproteins to porphyrins</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Simulated molecular docking of viral proteins with human heme or porphyrins with (LibDock tool) of Discovery-Studio 2016</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Favipiravir (
     <xref rid="b37-ijmm-46-02-0489" ref-type="bibr">37</xref>)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Accessory proteins: inhibits binding of E protein, ORF7a to porphyrin, prevent virus entering host cells</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Simulated molecular docking of viral proteins with human heme or porphyrins with (LibDock tool) of Discovery-Studio 2016</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
